Silence Therapeutics (SLN) News Today GBX 535 -5.00 (-0.93%) (As of 11/29/2021) Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Silence Therapeutics: Rising Assets Amid Growing LossesNovember 15, 2024 | markets.businessinsider.comStrong Financial Position and Promising Clinical Data Support Buy Rating for Silence TherapeuticsNovember 15, 2024 | markets.businessinsider.comSilence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 14, 2024 | finanznachrichten.deWe're Hopeful That Silence Therapeutics (NASDAQ:SLN) Will Use Its Cash WiselyOctober 28, 2024 | finance.yahoo.comSilence Therapeutics files automatic ordinary shares offeringOctober 23, 2024 | markets.businessinsider.comSilence Therapeutics plc (SLNCF)October 19, 2024 | finance.yahoo.comSilence Therapeutics: Strong Buy on Underappreciated Blockbuster Potential and Clinical AdvancementsAugust 30, 2024 | markets.businessinsider.comSilence Therapeutics plc (NASDAQ:SLN) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportAugust 18, 2024 | finance.yahoo.comSilence Therapeutics Second Quarter 2024 Earnings: Misses ExpectationsAugust 17, 2024 | finance.yahoo.comSilence Therapeutics (NASDAQ:SLN) Is In A Good Position To Deliver On Growth PlansMay 21, 2024 | finance.yahoo.comBuy Rating on Silence Therapeutics: Positive Phase 2 Data and Potential for Blockbuster RevenuesMay 17, 2024 | markets.businessinsider.comPause For Effect: Utilize Strategic SilenceMay 2, 2024 | forbes.comNissan to sell tiny Silence Nanocar – and it could come to the UKApril 30, 2024 | msn.comSheryl Sandberg Says ‘Screams Before Silence’ Is the Most Important Work She’s Ever Done: ‘Women’s Bodies Need to Be Protected’ | VideoApril 29, 2024 | yahoo.comBeyond The Numbers: 7 Analysts Discuss Silence Therapeutics StockApril 22, 2024 | markets.businessinsider.comSilence Therapeutics Plc American Depository Share (SLN)April 13, 2024 | nasdaq.com‘Quiet on Set’ to Launch Fifth Episode ‘Breaking the Silence’ With New Drake Bell Interview and MoreMarch 28, 2024 | msn.comSilence Therapeutics plc: Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business HighlightsMarch 13, 2024 | finanznachrichten.deSilence Therapeutics gains on mid-stage win for lead assetMarch 13, 2024 | msn.comSilence Therapeutics Jumps on Clinical TrialsFebruary 23, 2024 | msn.comBroker Revenue Forecasts For Silence Therapeutics plc (NASDAQ:SLN) Are Surging HigherFebruary 7, 2024 | finance.yahoo.comIs Silence Golden for This Small-Cap Biotech Stock?January 31, 2024 | realmoney.thestreet.comSilence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceJanuary 31, 2024 | finance.yahoo.comAll You Need to Know About Silence Therapeutics PLC Sponsored ADR (SLN) Rating Upgrade to Strong BuyJanuary 11, 2024 | msn.comSilence Therapeutics PLC Sponsored ADR (SLN) Is a Great Choice for 'Trend' Investors, Here's WhyJanuary 5, 2024 | finance.yahoo.comThis Silence Therapeutics Insider Increased Their Holding In The Last YearDecember 24, 2023 | finance.yahoo.comHere's Why Momentum in Silence Therapeutics PLC Sponsored ADR (SLN) Should Keep goingDecember 15, 2023 | finance.yahoo.comDoes Silence Therapeutics PLC Sponsored ADR (SLN) Have the Potential to Rally 187.05% as Wall Street Analysts Expect?December 6, 2023 | finance.yahoo.comSilence Therapeutics PLC ADR SLNNovember 21, 2023 | morningstar.comSilence Therapeutics: Bullish Outlook on SLN360 and Future Potential Despite Thalassemia Program DiscontinuationNovember 16, 2023 | markets.businessinsider.comIs This A Miracle Drug For 'Sticky Cholesterol'? Analysts Applaud Safety, Efficacy Of Silence Therapeutics' Heart Disease CandidateNovember 1, 2023 | markets.businessinsider.comSilence Therapeutics ADRs Rise 22% After Positive Trial ResultsNovember 1, 2023 | marketwatch.comEuropean Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday TradingOctober 27, 2023 | msn.comAT&T Unveils “Sound of Silence” Ad to Tout 5G Football Helmet PartnershipOctober 14, 2023 | msn.comSilence Therapeutics to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines ConferenceSeptember 26, 2023 | finance.yahoo.comWhere Silence Therapeutics Stands With AnalystsAugust 17, 2023 | markets.businessinsider.comSilence Therapeutics Plc (NASDAQ: SLN)June 25, 2023 | fool.comThe Latest Analyst Ratings for Silence TherapeuticsMay 11, 2023 | markets.businessinsider.comSilence Therapeutics plc: Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and DevelopmentMarch 28, 2023 | finanznachrichten.deSilence Therapeutics plc: Silence Therapeutics to Buyback siRNA Complement AssetsMarch 28, 2023 | finanznachrichten.deSilence Therapeutics to Buyback siRNA Complement AssetsMarch 28, 2023 | finance.yahoo.comSilence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and DevelopmentMarch 28, 2023 | finance.yahoo.comRaquel Leviss breaks her silence, Tom Sandoval finally apologizes to Ariana Madix: Here's the 'Scandoval' latestMarch 10, 2023 | yahoo.comSilence Therapeutics to Present at SVB Securities Global Biopharma ConferenceFebruary 8, 2023 | finance.yahoo.comSilence Therapeutics Appoints J.P. Gabriel as Chief Technical Operations OfficerFebruary 6, 2023 | wsj.comSilence Therapeutics Provides SLN360 and SLN124 Clinical Program UpdatesJanuary 12, 2023 | finance.yahoo.comSilence Therapeutics plc: Silence Therapeutics Reports Third Quarter 2022 ResultsNovember 10, 2022 | finanznachrichten.deSilence Therapeutics Announces Preliminary Single Dose Results from SLN124 Phase 1 Study in Patients with ThalassemiaSeptember 29, 2022 | finance.yahoo.comSilence Therapeutics to Participate in Fireside Chat at Chardan Genetic Medicines ConferenceSeptember 27, 2022 | finance.yahoo.comSilence Therapeutics plc: Silence Therapeutics Announces Pricing of Underwritten OfferingAugust 13, 2022 | finanznachrichten.de Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! SLN Media Mentions By Week SLN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLN News Sentiment▼0.670.47▲Average Medical News Sentiment SLN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLN Articles This Week▼30▲SLN Articles Average Week Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITH News GRI News INDV News BMY News GPH News IGC News PHAR News ARTL News KOD News AURA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SLN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silence Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Silence Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
